For ApoM, human adipose tissue studies reveal reduced ApoM expression in obesity and metabolic syndrome, genetic variants linked to type 2 diabetes, and decreased plasma ApoM in MASLD [96,97,98]. This evidence concerns the gene APOM and obesity due to melanocortin 4 receptor deficiency.